Studies indicate that Rybelsus is an effective treatment to manage blood sugar levels in people with type-2 diabetes. In a six-month long study, in which 782 patients were prescribed oral semaglutide tablets, individuals displayed a mean decrease of 0.9% in HbA1c from baseline. Patients with a higher baseline HbA1c also benefited from a greater reduction. This shows real-world improvement in diabetic control with Rybelsus.[popover id=ref9]